Rheumatoid Arthritis | Chart Trends | US | 2015

ChartTrends: Rheumatoid Arthritis 2015 (US) provides insight into the management and treatment of RA patients by rheumatologists based on actual patient-level data. 224 U.S. rheumatologists provided data on 999 biologic/Xeljanz-treated RA patients and were surveyed to examine what they self-report about disease management along with chart audit data for RA patients. Through an in-depth review of specific patient charts, details such as product dosing and frequency, prior medications/switching analysis, concomitant medications, and patient demographic variables help identify treatment approaches for RA.

launch Related Market Assessment Reports